Key facts
- This page summarizes Patrick Plewman's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 2 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 08 Mar 2023, 15:36.
Patrick Plewman - 06 Mar 2023 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- SVP for Diagnostic Services
- Issuer ticker
- DGX
- Reported as of
- 06 Mar 2023
- Net transaction value
- +$263,191
- SEC form
- 4
- Accepted by SEC
- 08 Mar 2023, 15:36:53 UTC
- Prior SEC filing
- 03 Mar 2023
- Next SEC filing
- 27 Mar 2023
- Source filing
- View source filing
- Reporting owner signature
- William J. O'Shaughnessy, Jr., Attorney in Fact for Patrick Plewman
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Patrick Plewman filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 08 Mar 2023.
Change
- Previous filing in this sequence was filed on 03 Mar 2023.
- Current net transaction value: +$263,191.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Award
- Transaction value
- $381,331
- Shares
- +2,579
- Change %
- +24%
- Price
- $147.86
- Shares after
- 13,145
- Date
- 06 Mar 2023
- Ownership
- Direct
- Footnotes
- F1
DGX
transaction
Common Stock
Tax liability
- Transaction value
- $118,140
- Shares
- -799
- Change %
- -6.1%
- Price
- $147.86
- Shares after
- 12,357
- Date
- 06 Mar 2023
- Ownership
- Direct
- Footnotes
- F2, F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
Stock issued by Quest Diagnostics Incorporated in settlement of a performance share award dated February 18, 2020, approved in accordance with the requirements of Rule 16b-3(d).
Footnote F2
Disposition of common stock to the issuer solely to cover tax withholding obligations arising from the settlement of said performance share award.
Footnote F3
The amount includes exempt purchases made under the Company's stock purchase plan since the date of the last filing on Form 4.